PATENT CLAIM ANALYSIS

Application Number: 15773512
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "189100"]

Abstract:
The present application provides immunotherapies for Hepatitis B virus infections. Provided herein are genetically modified arenaviral vectors suitable as vaccines for prevention and treatment of Hepatitis B virus infections. Also provided herein are pharmaceutical compositions and methods for the treatment of Hepatitis B virus infections. Specifically, provided herein are pharmaceutical compositions, vaccines, and methods of treating Hepatitis B virus infection.

Claim (Index 11):
The viral vector of any one of the preceding claims wherein the genomic information encoding the infectious arenavirus viral vector is derived from the lymphocytic choriomeningitis virus Clone 13 strain.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 93.0
- Lexical Diversity: 1.91429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15101363', '15580964', '14775484', '13037931', '12810382']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7812786898830204
- 35 USC 102 Novelty (BERT): 0.5562729244034912
- Combined Prediction Score: 0.7587781133350675
- Mean Citation Score: 372.36386
- Max Citation Score: 449.82828
- Similarity Product: 319.0362984340954

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test